Reata Pharmaceuticals revenue was $9.02 m in FY, 2020
Reata Pharmaceuticals revenue breakdown by business segment: 95.3% from License and Milestone and 4.7% from Other
|FY, 2019||FY, 2018||FY, 2017|
|Other Revenue||$1.24 m||$1.24 m||$955 k|
|License and Milestone||$25.28 m||$52.35 m||$47.1 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.